Physician profile
Javier R Gonzalez
NPI 1134114978
$728.25
in general payments reported to CMS, 2019-2025
18 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.35 · 2021: $263 · 2023: $108 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $108.19 | 2023 | Interstim |
| Abbvie INC. | $99.32 | 2021-2025 | |
| Pfizer INC. | $75.87 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.26 | 2025 | |
| Glaxosmithkline, LLC. | $46.35 | 2019 | |
| Amarin Pharma, INC. | $43.06 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $40.41 | 2025 | Breztri, Airsupra |
| Amgen INC. | $35.18 | 2021-2025 | Otezla, Repatha |
| Shield Therapeutics INC | $26.82 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.36 | 2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $23.16 | 2021 | |
| Ardelyx, INC. | $21.64 | 2025 | Ibsrela |
| Allergan, INC. | $21.24 | 2021 | |
| Novo Nordisk INC | $21.10 | 2021 | |
| Csl Behring | $21.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pbg Puerto Rico LLC | $17.40 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.62 | 2021 | |
| Astellas Pharma US INC | $16.27 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.